Fujisawa, Japan

Toshihiko Kumamoto

This inventor holds 1 USPTO granted patent. Top assignee: Mercian Corporation. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshihiko Kumamoto. Retrieved from https://idiyas.com/inventor/toshihiko-kumamoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Toshihiko Kumamoto

Introduction

Toshihiko Kumamoto is a notable inventor based in Fujisawa, Japan. He has made significant contributions to the field of antibiotics, particularly with his innovative work on Mer-AF1032A and Mer-AF1032B. His research has the potential to impact the pharmaceutical industry positively.

Latest Patents

Kumamoto holds a patent for antibiotics Mer-AF1032A and Mer-AF1032B. The antibiotic Mer-AF1032A is represented by a specific formula, along with its isomer, antibiotic Mer-AF1032B. His patent also includes a method for preparing these antibiotics, which involves cultivating a strain belonging to the genus Penicillium. Additionally, he has developed a pharmaceutical composition that includes one of these antibiotics, which is useful as an antifungal agent.

Career Highlights

Kumamoto is associated with Mercian Corporation, where he has been able to apply his expertise in antibiotic development. His work has contributed to advancements in the field, showcasing his dedication to improving healthcare through innovative solutions.

Collaborations

Some of his notable coworkers include Hitosi Agematu and Yoshio Watanabe. Their collaboration has likely enhanced the research and development process within their projects.

Conclusion

Toshihiko Kumamoto's contributions to antibiotic research exemplify the importance of innovation in healthcare. His work on Mer-AF1032A and Mer-AF1032B highlights the potential for new treatments in the fight against infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…